Claim your Discounted CogniCare Pro Below
While Stock Lasts

Try One

30 Day Supply

$69

Per Bottle

90 Day Money-Back Guarantee

TOTAL: $69

+ SHIPPING

Best Value

180 Day Supply

$49

Per Bottle

+ 2 FREE E-BOOKS

90 Day Money-Back Guarantee

TOTAL: $294

+ SHIPPING

Most Popular

90 Day Supply

$59

Per Bottle

+ 2 FREE E-BOOKS

90 Day Money-Back Guarantee

TOTAL: $177

+ SHIPPING

Supports Your Memory Enhancement Goals

Proven natural ingredients: Studies have shown that Green Coffee Beans and plant-sourced PS (phosphatidylserine) have a positive effect on brain performance. 

Plant Ingredients

No Stimulants 

Non-Habit Forming

* SPECIAL OFFER EVERY ORDER OF 6 BOTTLES GETS FREE SHIPPING!

100% Satisfaction Guaranteed 90-Day Money Back Guarantee

CogniCare Pro comes with a 100% money back guarantee – 90 full days from your original purchase. If you’re not totally and completely satisfied with our product or your results within the first 90 days simply let us know by calling our toll-free number or dropping us an email and we’ll gladly give you a full refund within 48 hours of the product being returned. That’s right – simply return the product, even your empty bottles, anytime within 90 days of your purchase and you’ll receive a full, no-questions-asked refund (minus shipping and handling fees).

Scientific References

The company is not endorsed by, sponsored by, or affiliated with any of these organizations

  1. Chronic Inflammation Linked to Dementia – Alissa Sauer – 2018
  2. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer’s disease – R Wang – 2005
  3. L-Carnitine Supplementation in Older Women. A Pilot Study on Aging Skeletal Muscle Mass and Function – AK Sawicka – 2018
  4. Reduced Alzheimer’s disease pathology by St. John’s wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice – J Hofrichter – 2013
  5. Effects of Tooth Loss and the Apolipoprotein E ɛ4 Allele on Mild Memory Impairment in the Fujiwara-kyo Study of Japan: A Nested Case-Control Study – N Okamoto – 2017
  6. Neuropsychological Training of Attention Improves MS-Related Fatigue: Results of a Randomized, Placebo-Controlled, Double-Blind Pilot Study – P Flachenecker – 2017
  7. Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies – ASA Manap – 2019
  8. Reduced Alzheimer’s disease pathology by St. John’s wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice – J Hofrichter – 2013
  9. Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function – M Kamceva – 2016
  10. In search for Alzheimer’s drug, a major STEP forward – KN Peart – 2014
  11. A common STEP in the synaptic pathology of diverse neuropsychiatric disorders – MA Johnson – 2012
  1. A STEP forward in neural function and degeneration – ML Baum – 2010
  2. Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer’s disease – J Xu – 2014
  3. Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer’s disease mouse model – Y Zhang – 2010
  4. Drug reverses brain deficits of Alzheimer’s in mouse model – Yale University – 2014
  5. Further evidence that controlling high blood pressure can reduce dementia, Alzheimer’s risk – 2019
  6. Blood Pressure and Dementia – a Comprehensive Review – SP Kennelly – 2009
  7. How the brain’s immune system could be harnessed to improve memory – RMIT University – 2020
  8. Alzheimer’s wake-up call – 2017
  9. Effects of phosphatidylserine in Alzheimer’s disease – T Crook – 2017
  10. Effect of Phosphatidylserine on Cerebral Glucose Metabolism in Alzheimer’s Disease – P Klinkhammer – 1990
  11. Efficacy of vinpotropile in the therapy of initial signs of cerebrovascular pathology – 2010
  12. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial – C Calabrese – 2008

Statements on this website have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure or prevent any disease.

The website’s content and the product for sale is based upon the author’s opinion and is provided solely on an “AS IS” and “AS AVAILABLE” basis. You should do your own research and confirm the information with other sources when searching for information regarding health issues and always review the information carefully with your professional health care provider before using any of the protocols presented on this website and/or in the product sold here. Neither ClickBank nor the author are engaged in rendering medical or similar professional services or advice via this website or in the product, and the information provided is not intended to replace medical advice offered by a physician or other licensed healthcare provider. You should not construe ClickBank’s sale of this product as an endorsement by ClickBank of the views expressed herein, or any warranty or guarantee of any strategy, recommendation, treatment, action, or application of advice made by the author of the product.

Some names and personal identifying information on this site have been changed to protect the privacy of individuals.

ClickBank is the retailer of products on this site. CLICKBANK® is a registered trademark of Click Sales Inc., a Delaware corporation located at 1444 S. Entertainment Ave., Suite 410 Boise, ID 83709, USA and used by permission. ClickBank’s role as retailer does not constitute an endorsement, approval or review of these products or any claim, statement or opinion used in promotion of these products.

      For Product Support, please contact the vendor here.

For Order Support, please contact ClickBank here.

© CogniCare Pro Research 2024 All Rights Reserved.